Syrup
S.NO | GENERIC NAME & DOSAGE FORM. | COMPOSITION |
---|---|---|
1 | Dextromethorphan Hydrobromide, Chlorpheniramine Maleate & Menthol Syrup | Each 5ml contains: |
Dextromethorphan Hydrobromide | ||
Chlorpheniramine Maleate | ||
Menthol | ||
In a flavoured syrupy base | ||
Approved colour used | ||
2 | Chlorpheniramine Maleate, Phenylephrine Hydrochloride & Dextromethorphan Hydrobromide Syrup | Each 5ml contains: |
Chlorpheniramine Maleate | ||
Phenylephrine Hydrochloride | ||
Dextromethorphan Hydrobromide | ||
In a flavoured syrupy base | ||
Approved colour used | ||
3 | Terbutaline Sulphate, Bromhexine Hcl & Guaiphenesin Tablets | Each uncoated tablet contains: |
Terbutaline Sulphate | ||
Bromhexine Hcl | ||
Guaiphenesin | ||
Excipients | ||
Approved colour used | ||
4 | Terbutaline Sulphate, Bromhexine Hcl, Guaiphenesin & Menthol Syrup | Each 10ml contains: |
Terbutaline Sulphate | ||
Bromhexine Hcl | ||
Guaiphenesin | ||
Menthol | ||
Excipients | ||
Approved colour used | ||
5 | Ferrous ascorbate & folic acid suspension | Each 5ml contains:- |
Ferrous Ascorbate Eq. to Elemental Iron | ||
Folic Acid | ||
In a flavoured suspension base | ||
Approved colour used | ||
6 | Cyproheptadine Hydrochloride & Tricholine Citrate Syrup | Each 5 ml contains:- |
Cyproheptadine Hydrochloride | ||
Tricholine Citrate 65% | ||
In a flavoured syrupy base | ||
Approved colour used | ||
7 | Mefenamic Acid & Paracetamol Oral Suspension | Each 5 ml Contains:- |
Mefenamic Acid | ||
Paracetamol | ||
In a flavoured suspension base | ||
Approved colour used | ||
8 | Citicoline Syrup | Each 5 ml Contains:- |
Citicoline Sodium Eq. to Citicoline | ||
In a flavoured syrupy base | ||
Approved colour used | ||
9 | Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup | Each 5 ml Contains:- |
Phenylephrine Hydrochloride | ||
Chlorpheniramine Maleate | ||
In a flavoured syrupy base | ||
Approved colour used | ||
10 | Oxetacaine, Dried Aluminium Hydroxide Gel & Magnesium Hydroxide Oral suspension | Each 5 ml Contains:- |
Oxetacaine | ||
Dried Aluminium Hydroxide Gel | ||
Magnesium Hydroxide | ||
In a flavoured suspension base | ||
Approved colour used | ||
11 | Ambroxol Hydrochloride, Guaiphenesin & Levosalbutamol Syrup | Each 5 ml Contains:- |
Ambroxol Hydrochloride | ||
Guaiphenesin | ||
Levosalbutamol Sulphate Eq. to Levosalbutamol | ||
In a mentholated syrupy base | ||
Approved colour used | ||
12 | Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate & Menthol Syrup | Each 5 ml Contains:- |
Ambroxol Hydrochloride | ||
Guaiphenesin | ||
Terbutaline Sulphate | ||
Menthol | ||
In a flavoured syrupy base | ||
Approved colour used | ||
13 | Ofloxacin Oral Suspension IP | Each 5 ml Contains: – |
Ofloxacin | ||
In a flavoured suspension base | ||
Approved colour used | ||
14 | Ofloxacin Oral Suspension IP | Each 5 ml Contains: – |
Ofloxacin | ||
In a flavoured suspension base | ||
Approved colour used | ||
15 | Sodium Picosulfate Oral Solution BP | Each 5 ml Contains: – |
Sodium Picosulfate | ||
In a sorbitol base | ||
Approved colour used | ||
16 | Sucralfate &Oxetacaine Suspension | Each 10 ml contains: – |
Sucralfate | ||
Oxetacaine | ||
In a flavoured suspension base | ||
Approved colour used | ||
17 | Magaldrate &Simethicone Suspension IP | Each 5 ml contains:- |
Magaldrate (as anhydrous) | ||
Simethicone | ||
In a flavoured suspension base | ||
Approved colour used | ||
18 | Paracetamol Paediatric Oral Suspension IP | Each 5 ml contains:- |
Paracetamol | ||
In a flavoured suspension base | ||
Approved colour used | ||
19 | OndansetronOral solution IP | Each 5 ml contains:- |
Ondansetron Hydrochloride Eq. to Ondansetron | ||
In a flavoured solution base | ||
Approved colour used | ||
20 | OndansetronOral solution IP | Each 5 ml contains:- |
Ondansetron Hydrochloride Eq. to Ondansetron | ||
In a flavoured solution base | ||
Approved colour used | ||
21 | Azithromycin Oral Suspension IP | Each ml contains:- |
Azithromycin Dihydrate Eq. to Azithromycin | ||
In a flavoured suspension base | ||
Approved colour used | ||
22 | Paracetamol Paediatric Oral Suspension IP | Each 5 ml contains:- |
Paracetamol | ||
In a flavoured suspension base | ||
Approved colour used | ||
23 | Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride& Chlorpheniramine Maleate Syrup | Each 5 ml Contains:- |
Dextromethorphan Hydrobromide | ||
Phenylephrine Hydrochloride | ||
Chlorpheniramine Maleate | ||
In a flavoured syrupy base | ||
Approved colour used | ||
24 | Mefenamic Acid & Paracetamol Oral Suspension | Each 5 ml Contains:- |
Mefenamic Acid | ||
Paracetamol | ||
In a flavoured suspension base | ||
Approved colour used | ||
25 | Albendazole suspension IP 200 mg | Each 5 ml Contains:- |
Albendazole | ||
In a flavoured suspension base | ||
Approved colour used | ||
26 | Deflazacort oral suspension | Each 5 ml Contains:- |
Deflazacort | ||
In a flavoured suspension base | ||
Approved colour used | ||
27 | Ambroxol Hydrochloride, Guaiphenesin & Terbutaline Sulphate Syrup | Each 5 ml Contains:- |
Ambroxol Hydrochloride | ||
Guaiphenesin | ||
Terbutaline Sulphate | ||
In a flavoured syrupy base | ||
Approved colour used | ||
28 | Dried Aluminium Hydroxide Gel, Magnesium Hydroxide & Simethicone Suspension | Each 10 ml Contains:- |
Dried Aluminium Hydroxide Gel Eq. to Aluminium Hydroxide | ||
Magnesium Hydroxide | ||
Activated Dimethiicone (Simethicone) | ||
In a flavoured suspension base | ||
Approved colour used | ||
29 | Ofloxacin & Metronidazole Suspension | Each 5 ml contains:- |
Ofloxacin | ||
Metronidazole Benzoate Eq. to Metronidazole | ||
In a flavoured suspension base | ||
Approved colour used | ||
30 | Elemental Calcium, Vitamin D3 & Cyanocobalamin Suspension | Each 10 ml contains:- |
Calcium Carbonate (Oyster Shell) Eq. to Elemental Calcium | ||
Vitamin D3 | ||
Cyanocobalamin | ||
In a flavoured suspension base | ||
Approved colour used | ||
31 | Levetiracetam Oral Solution IP | Each 5 ml contains:- |
Levetiracetam | ||
In a flavoured aquves vhecals base | ||
Approved colour used | ||
32 | Levocloperastine Fendizoate Oral Suspension | Each 5 ml contains:- |
Levocloperastine Fendizoate Eq. to Levocloperastine Hydrochloride | ||
In a flavoured suspension base | ||
Approved colour used | ||
33 | Levodropropizine & Chlorpheniramine Syrup | Each 5 ml contains:- |
Levodropropizine | ||
Chlorpheniramine Maleate | ||
In a flavoured syrupy base | ||
Approved colour used | ||
34 | Phenylephrine Hydrochloride, Chlorpheniramin e Maleate, Sodium Citrate & Menthol Syrup | Each 5 ml contains:- |
Phenylephrine Hydrochloride | ||
Chlorpheniramine Maleate | ||
Sodium Citrate | ||
Menthol | ||
In a flavoured syrupy base | ||
Approved colour used | ||
35 | Salbutamol & Etofylline Syrup | Each 5 ml contains:- |
Salbutamol Sulphate Eq. to Salbutamol | ||
Etofylline | ||
In a flavoured syrupy base | ||
Approved colour used | ||
36 | Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate, Sodium Citrate , Ammonium Chloride & Menthol Suspension | Each 5 ml contains:- |
Paracetamol | ||
Phenylephrine Hydrochloride | ||
Chlorpheniramine Maleate | ||
Sodium Citrate | ||
Ammonium Chloride | ||
Menthol | ||
In a flavoured suspension base | ||
Approved colour used | ||
37 | Ambroxol Hydrochloride & Guaiphenesin Syrup | Each 5 ml contains:- |
Ambroxol Hydrochloride | ||
Guaiphenesin | ||
In a flavoured syrupy base | ||
Approved colour used | ||
38 | Ambroxol Hydrochloride & Cetirizine Hydrochloride Syrup | Each 5 ml contains:- |
Ambroxol Hydrochloride | ||
Cetirizine Hydrochloride | ||
In a flavoured syrupy base | ||
Approved colour used | ||
39 | Dicyclomine Hydrochloride & Activated Dimethicone oral Suspension | Each 5 ml contains:- |
Dicyclomine Hydrochloride | ||
Activated Dimethicone | ||
In a flavoured suspension base | ||
Approved colour used | ||
40 | Magaldrate, Simethicone & Oxetacaine Suspension | Each 5 ml contains:- |
Magaldrate (as anhydrous) | ||
Simethicone | ||
Oxetacaine | ||
In a flavoured syrupy base | ||
Approved colour used | ||
41 | Cyanocobalamin, Folic Acid & Niacinamide oral Drops | Each 5ml contains:- |
Cyanocobalamin (Anhydrous) | ||
Folic Acid | ||
Niacinamide | ||
In a flavoured syrupy base | ||
Approved colour used | ||
42 | Potassium Citrate & Citric Acid oral Solution USP | Each 5 ml contains:- |
Potassium Citrate Monohydrate | ||
Citric Acid Monohydrate | ||
In a flavoured syrupy base | ||
Approved colour used | ||
43 | Iron (III) Hydroxide Polymaltose & Folic Acid Oral Drops | Each ml contains:- |
Iron (III) Hydroxide Polymaltose Complex Eq. to Elemental Iron | ||
Folic Acid | ||
In a flavoured base | ||
Approved colour used | ||
44 | Dicyclomine Hydrochloride & Simethicone oral Drops | Each ml contains:- |
Dicyclomine Hydrochloride | ||
Simethicone Emulsion Eq. to Simethicone | ||
In a flavoured base | ||
Approved colour used | ||
45 | Ambroxol Hydrochloride, Guaiphenesin & Terbutaline Sulphate Drops | Each ml Contains:- |
Ambroxol Hydrochloride | ||
Guaiphenesin | ||
Terbutaline Sulphate | ||
In a mentholated syrupy base | ||
Approved colour used | ||
46 | Levocetirizine Dihydrochloride Syrup IP | Each 5ml contains:- |
Levocetirizine Dihydrochloride | ||
In a flavoured syrupy base | ||
Approved colour used | ||
47 | Calcium & Vitamin D3 Suspension | Each 5ml contains:- |
Calcium Carbonate Eq. to elemental Calcium From an Organic source (Oyster Shells) | ||
Vitamin D3 | ||
In a flavoured Suspension base | ||
Approved colour used | ||
48 | Phenylephrine Hydrochloride & Chlorpheniramin e Maleate Syrup | Each 5ml contains:- |
Phenylephrine Hydrochloride | ||
Chlorpheniramine Maleate | ||
In a flavoured Syrupy base | ||
Approved colour used | ||
49 | Liquid Paraffin, Milk of Magnesia & Sodium Picosulfate Suspension | Each 5ml contains:- |
Liquid Paraffin | ||
Milk of Magnesia | ||
Sodium Picosulfate | ||
In a flavoured Sorbitol base | ||
Approved colour used | ||
50 | Magaldrate, Simethicone & Oxetacaine Suspension | Each 5 ml contains:- |
Magaldrate (as anhydrous) | ||
Simethicone | ||
Oxetacaine | ||
In a flavoured syrupy base | ||
Approved colour used | ||
51 | Cyproheptadine Hydrochloride & Tricholine Citrate oral Drops | Each ml contains:- |
Cyproheptadine Hydrochloride (as anhydrous) | ||
Tricholine Citrate 65% | ||
In a flavoured syrupy base | ||
Approved colour used | ||
52 | Albendazole & Ivermectin oral Suspension | Each 5 ml Contains:- |
Albendazole | ||
Ivermectin | ||
In a flavoured syrupy base | ||
Approved colour used | ||
53 | Ferric Ammonium Citrate, Folic Acid & Cyanocobalamin Syrup | Each 15 ml Contains:- |
Ferric Ammonium Citrate | ||
Folic Acid | ||
Cyanocobalamin | ||
In a flavoured syrupy base | ||
Approved colour used | ||
54 | Potassium Chloride Oral Solution USP 20% | Each 15 ml contains:- |
Potassium Chloride | ||
In a flavoured syrupy base | ||
Approved colour used | ||
55 | Ambroxol Hydrochloride, Guaiphenesin & Levosalbutamol Syrup | Each 5 ml contains:- |
Ambroxol Hydrochloride | ||
Guaiphenesin | ||
Levosalbutamol Sulphate Eq. to Levosalbutamol | ||
In a flavoured syrupy base | ||
Approved colour used | ||
56 | Ambroxol Hydrochloride, Guaiphenesin & Levosalbutamol Syrup | Each 5 ml contains:- |
Ambroxol Hydrochloride | ||
Guaiphenesin | ||
Levosalbutamol Sulphate Eq. to Levosalbutamol | ||
In a flavoured syrupy base | ||
Approved colour used | ||
57 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension | Each 5 ml contains:- |
Paracetamol | ||
Phenylephrine Hydrochloride | ||
Chlorpheniramine Maleate | ||
In a flavoured suspension base | ||
Approved colour used | ||
58 | Levocetirizine Dihydrochloride & Montelukast Syrup | Each 5 ml contains:- |
Levocetirizine Dihydrochloride | ||
Montelukast Sodium Eq. to Montelukast | ||
In a flavoured syrupy base | ||
Approved colour used | ||
59 | Magaldrate & Simethicone Suspension IP | Each 10 ml contains:- |
Magaldrate (as anhydrous) | ||
Simethicone | ||
In a flavoured suspension base | ||
Approved colour used | ||
60 | Vitamin D3 Oral Solution 60000 IU | Each 5 ml contains:- |
Cholecalciferol Concentrate (as Stabilized) Eq. to Cholecalciferol (Vitamin D3) (In Nano Droplet From) | ||
In a flavoured Sorbitol (70%) base (Non Crystallising) | ||
61 | Ibuprofen & Paracetamol Suspension | Each 5 ml contains:- |
Ibuprofen | ||
Paracetamol | ||
In a flavoured suspension base | ||
Approved colour used | ||
62 | Magaldrate & Simethicone Suspension IP | Each 10 ml contains:- |
Magaldrate (as anhydrous) | ||
Simethicone | ||
Sorbitol Solution (70%) (non-crystallising) | ||
Approved colour used | ||
63 | Aceclofenac & Paracetamol Suspension | Each 5ml contains:- |
Aceclofenac | ||
Paracetamol | ||
In a flavoured syrupy base | ||
Approved colour used | ||
64 | Cyproheptadine Hydrochloride & Tricholine Citrate Syrup | Each 5 ml contains:- |
Cyproheptadine Hydrochloride Eq. to Anhydrous Cyproheptadine Hydrochloride | ||
Tricholine Citrate 65% | ||
In a flavoured sorbitol (70%) base (Non-Crystallising) | ||
Approved colour used | ||
65 | Disodium Hydrogen Citrate Syrup | Each 5 ml contains:- |
Disodium Hydrogen Citrate | ||
In a flavoured syrupy base | ||
Approved colour used | ||
66 | Lactulose Oral Solution USP | Each 15 ml contains:- |
Lactulose Concentrate Eq. to Lactulose | ||
Palatable base | ||
Approved colour used | ||
67 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Oral Drops | Each 1 ml contains:- |
Paracetamol | ||
Phenylephrine Hydrochloride | ||
Chlorpheniramine Maleate | ||
In a flavoured syrupy base |